Journal for ImmunoTherapy of Cancer’s Post

This #LiverAwarenessMonth, Taconic spotlights the NASH B6 model, which has led to many successful #MASH studies. In our on-demand webinar, learn from Taconic's Field Applications Scientist Laura Griffin PhD about how these murine models can advance your preclinical research: https://hubs.li/Q02Ssj3v0

Preclinical Models of Pemphigus

Artificial intelligence is being touted as protection against the pitfalls of discovering and developing new drugs. Several companies have staked claims about being first or faster with their AI platforms, but none have yet taken a fully AI-generated molecule from discovery all the way through clinical development. #ArtificialIntelligence #AtopicDermatitis #ClinicalTrials #Cancer #DrugDiscovery #MachineLearning #Schizophrenia

Efficient Nebulization and Pulmonary Biodistribution of Polymeric Nanocarriers in an Acute Lung Injury Preclinical Model A new article has been published in the Journal Small Science: https://bit.ly/3RQk88z

Did you know that a whopping 83% of CAR-T lead candidates face hurdles post-preclinical development? The journey towards innovative therapies has been riddled with challenges, but we're on the brink of a breakthrough! 💡 For too long, we've relied heavily on traditional in vitro assays, like cytokine secretion and killing, providing valuable but limited insights. The missing piece? 🤔Understanding cellular interaction! Thanks to recent advancements, we're rewriting the rules and breaking free from the limitations of the past. 🔬 Join us on this transformative cell avidity journey and embrace new possibilities in CAR-T development! Together, we're not just redefining standards but creating a future where success rates soar and costs plummet. 📈 Check out this page to learn more! https://lnkd.in/gZH492PH #CAR-TInnovation #FutureOfMedicine #ScientificBreakthroughs

In this on-demand webinar with Precision For Medicine, Drs. Dawn Lain Butler and Amanda Woodrooffe guide you through the essential aspects of IHC, including its importance in biomarker validation and the transition from preclinical assay development to early clinical application. View it now! https://lnkd.in/gjpQmQmU

Looking for ways to improve your preclinical IBD research? Join Dr. Philip Dubé tomorrow for an insightful webinar on the adoptive T cell transfer colitis model. Discover key factors for success and participate in a live Q&A session. Register now: https://bit.ly/4duNZwE #colitis #ibdresearch

AI has a data problem: there's too little quality biological data to keep up with validation and training of advanced drug discovery models. In his talk today, Matt Beaudet shared critical insights to answer one of the most crucial questions in drug discovery today, pointing to the power of ultra-fast cell imaging and analysis to bridge the gap between digital models and real-world therapeutics. Catch Matt and our team at DDIF today and tomorrow—we’d love to connect and share our vision for the future of drug discovery! #DDIF #DDIF2024 #drugdiscovery #techbio #aidrugdiscovery #ai

Unveiling the Future of Medicine: PDX Models Want drugs that truly replicate human response? Look no further than Patient-Derived Xenografts (PDXs)! These models bridge the gap between lab & patient, offering: Unmatched Accuracy: PDXs mirror genetic & functional tumor traits, paving the way for personalized medicine.🧬 Drug Discovery Powerhouse: Test & optimize treatments in a human-relevant setting, boosting success rates.🚀 Accelerated Research: Skip limitations of cell lines, speeding up development of life-saving therapies. PDXs hold the key to unlocking better, faster clinical trials. Let's harness their power for healthier tomorrows! #ClinicalResearch #PDX #PersonalizedMedicine #DrugDiscovery #FutureOfMedicine 🌐 #ClinicalResearch #PrecisionMedicine #PDXModels #MedicalInnovation 🏥💊 #xenografts

😎 It's tomorrow! Don't miss the webinar "Drug Response Profiling of Primary Colorectal Tumor Models using spheroONE Pu·MA System EC". This webinar is a collaborative effort between PFI, MatTek Life Sciences, SCIENION, and Cellenion. 🚀🔬 Primary tumoroids are sorted & dispensed into flowchips for drug testing using phenotypic assays. Automated compound incubation and viability staining lead to consistent reproducible high-quality data. This platform is a valuable tool in a wide range of research areas enabling multiplex disease modeling, drug discovery and personalized medicine. 📅 Date: May 29, 2024 🕒 Time: 8 am PDT / 11 am EDT / 5 pm CET 📍 Register here: https://lnkd.in/grHujeWu Register now! #webinar #spheroids #organoids #tumoroids #3dcellularmodels #flowchips #microfluidics #drugtesting #automation